tiprankstipranks
Medigene AG (DE:MDG1)
:MDG1
Germany Market
MDG1
Medigene
RESEARCH TOOLSreports

Medigene (MDG1) Income Statement

― Followers

Medigene Income Statement

Last quarter (Q2 2024), Medigene's total revenue was €1.46M, a decrease of -6.00% from the same quarter last year. In Q2, Medigene's net income was €-4.08M. See Medigene’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
€ 6.03M€ 31.25M€ 10.46M€ 8.75M€ 10.63M
Gross Profit
€ 4.39M€ 29.26M€ 9.10M€ 7.46M€ 10.25M
Operating Expenses
€ 20.54M€ 37.99M€ 19.09M€ 30.79M€ 30.41M
Depreciation and Amortization
€ 1.46M€ 21.85M€ 3.43M€ 6.47M€ 2.37M
EBITDA
€ -14.58M€ 13.14M€ -6.49M€ -21.53M€ -17.10M
Operating Income
€ -16.15M€ -8.73M€ -9.98M€ -23.33M€ -20.16M
Other Income/Expenses
€ -443.00K€ -647.00K€ -298.00K€ 261.00K€ 243.00K
Pretax Income
€ -16.59M€ -9.37M€ -10.28M€ -28.40M€ -19.92M
Net Income
€ -16.18M€ -8.33M€ -9.98M€ -28.88M€ -19.96M
Per Share Metrics
Basic EPS
€ -1.25€ -0.65€ -0.78€ -1.18€ -0.81
Diluted EPS
€ -1.25€ -0.65€ -0.78€ -1.18€ -0.81
Weighted Average Shares Outstanding
 12.93M 12.93M 12.93M 24.56M 24.56M
Weighted Average Shares Outstanding (Diluted)
 12.93M 12.93M 12.93M 24.56M 24.56M
Currency in EUR

Medigene Earnings and Revenue History